Remimazolam vs. Propofol for Sedation After Cardiac Surgery in Older Adults
Official title: Effects of Remimazolam Tosylate Versus Propofol for Postoperative Sedation on the Incidence of Postoperative Delirium in Older Patients Undergoing Cardiac Surgery: A Prospective, Double-Blind, Randomized Controlled Trial
Run by Nanjing First Hospital, Nanjing Medical University · NCT07908121 · Data updated 2026-11-12
This trial tests whether remimazolam tosylate can lower the rate of postoperative delirium compared with propofol in patients 65 and older after cardiac surgery with bypass.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 90 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Nanjing First Hospital, Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | September 5, 2026 |
| Main results expected | December 23, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07908121 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65 and older undergoing elective cardiac surgery with bypass and anticipated need for mechanical ventilation and sedation for at least 2 hours in the cardiac surgery ICU.
✕Probably not a fit
Patients with preexisting delirium, severe dementia, certain complex or emergent cardiac procedures, or severe alcohol use disorder may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective, randomized, double-blind, double-dummy, active-controlled superiority trial enrolling 600 patients aged 65 or older undergoing elective cardiac surgery with cardiopulmonary bypass. Participants are randomized 1:1 to receive either remimazolam tosylate or propofol for continuous ICU sedation, with dose adjustments to maintain a target RASS of -2 to 0 and standardized analgesia. The primary aim is to determine if remimazolam tosylate reduces the incidence of postoperative delirium compared with propofol. The study excludes emergency surgeries, certain complex cardiac procedures, severe psychiatric conditions, dementia, and recent substantial alcohol misuse. Outcomes include delirium incidence and safety under standardized postoperative care in the ICU.
Why it matters
Potential benefit: If successful, remimazolam tosylate could reduce postoperative delirium and improve recovery after cardiac surgery in older adults.
How similar studies have gone: Randomized trials in anesthesia have explored alternative sedatives for delirium, with some showing potential delirium reduction, but data specific to remimazolam in this setting are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1\. Age ≥65 years. 2. Undergoing elective cardiac surgery with cardiopulmonary bypass, including coronary artery bypass grafting (CABG), valve surgery, or combined CABG and valve surgery. 3\. Admission to the cardiac surgery intensive care unit (ICU) after surgery, with an anticipated need for invasive mechanical ventilation and continuous sedation for at least 2 hours. 4\. Written informed consent obtained from the participant or their legally authorized representative. 5\. No delirium identified during the preoperative assessment. Exclusion Criteria 1. Emergency or salvage cardiac surgery. 2. Heart transplantation, ventricular assist device implantation, surgery for aortic dissection requiring deep hypothermic circulatory arrest, or other cardiac procedures outside the scope of this study. 3. Severe psychiatric disorders, diagnosed Alzheimer's disease or dementia, or preoperative delirium. 4. Severe alcohol use disorder or a history of severe alcohol misuse. 5. Previous cerebrovascular events or other conditions causing severe visual, hearing, or communication impairment that would prevent reliable delirium assessment despite appropriate assistance. 6. Known hypersensitivity or contraindications to either study drug or its excipients, or severe hepatic or renal failure. 7. Decompensated acute circulatory failure or hemodynamic instability at the time of randomization. 8. Concurrent participation in another interventional clinical trial that could affect the primary outcome.
Where it's running
-
Nanjing First Hospital
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: liang hong, doctor
- Email: hlblade@gmail.com
- Phone: +86 13914755401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized iPad audio messages to reduce confusion after hip fracture surgery
This trial will try 2-minute personalized audio reorientation messages on an iPad to see if they help prevent confusion (delirium) in people aged 60 and over after hip fracture surgery.
-
Impact of Fast-Track Anesthesia on Postoperative Delirium After Cardiac Surgery
This observational study tests whether fast-track anesthesia, compared with conventional care, is linked to lower rates of delirium after elective cardiac surgery in adults.
-
Dexmedetomidine to See if Delirium Drops After Hip Fracture Surgery
This observational study tests whether using dexmedetomidine around hip fracture surgery helps prevent postoperative delirium in adults 65 and older.
-
How different pain control methods affect early mobilization after major surgery in older ICU patients
In this real-world study, researchers will observe how pain-relief methods used after major surgery in adults 65 and older in the ICU relate to how quickly they get out of bed and start moving.
-
VR-based cognitive games to help prevent delirium after big surgery
A VR-based cognitive stimulation game is being tested to see if it can help prevent delirium in adults 65 and older after major surgery.
-
Sleep problems before heart surgery may affect recovery outcomes
This study tests whether preoperative sleep issues in adults undergoing cardiac surgery are linked to different perioperative metabolites and postoperative outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.